LONDON (MarketWatch) -- AstraZeneca PLC will consider acquiring branded generic drugs in emerging countries as it boosts its business outside the U.S. and Europe, Chief Executive David Brennan said Tuesday.
LONDON (MarketWatch) -- AstraZeneca PLC will consider acquiring branded generic drugs in emerging countries as it boosts its business outside the U.S. and Europe, Chief Executive David Brennan said Tuesday.
